ARTICLE | Clinical News
Herceptin trastuzumab regulatory update
September 27, 2010 7:00 AM UTC
FDA issued a new quarterly report on safety information emerging from its Adverse Events Reporting System (AERS) during 2Q10 in which the agency identified a possible risk of neonatal pulmonary hypopl...